Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Symptoms typically peak during treatment initiation and dose escalation, gradually diminishing over 812 weeks in most patients
Due to MTII's broad, non-selective receptor activity, researchers and regulatory agencies have raised concerns about potential effects on melanocytic nevi (moles) and theoretical melanoma risk through excessive MC1R stimulation
Some patients experienced developmental delays and other long-term sequelae (e.g
Enter your shipping preference and billing information at checkout
US$ 23.61
US$ 26.93
US$ 22.19
US$ 25.70
US$ 21.47
US$ 21.89
US$ 20.74
US$ 20.91
US$ 21.75
US$ 21.30
US$ 20.54
US$ 22.55
US$ 29.09
US$ 20.72
US$ 20.20
